TARS Financials
Tarsus Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$67.24
Market Cap
$2.88B
EPS
$-1.59
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$182.95M
Gross Profit
-
Operating Income
-
Net Income
$-115.55M
EPS (Diluted)
$-3.07
Balance Sheet Highlights
Total Assets
$376.99M
Total Liabilities
$152.46M
Shareholders Equity
-
Cash & Equivalents
$94.82M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-83.03M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
79.0%
Operating Margin
-0.1%
Net Margin
-0.1%
ROE
-0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TARS revenue?
TARS's most recent quarterly revenue was $182.95M. Annual revenue can be calculated by summing the four most recent quarters.
Is TARS profitable?
TARS reported a loss of $115.55M in the most recent quarter. The net profit margin is -0.1%.
What is TARS market cap?
TARS has a market capitalization of $2.88B, making it a mid-cap stock.
Does TARS have debt?
View TARS's balance sheet for debt information.
What is TARS cash flow?
Cash flow data is available in the full financial statements.